Burden of Vitiligo in Canada: Retrospective Analysis of a Canadian Public Claims Database.

ABSTRACT:

Background

Vitiligo is an autoimmune disease resulting in skin depigmentation. Treatment options are limited.

Objectives

To examine disease burden and healthcare resource utilization (HCRU) among patients with vitiligo in Québec, Canada.

Methods

In this retrospective study, data were obtained from the Régie de l'Assurance Maladie du Québec (RAMQ) databases for 125,000 random individuals from January 2010 to December 2019. The International Classification of Diseases, Ninth Revision (ICD-9) diagnostic code [709.x (other skin disorders)] with vitiligo-related treatment was used to identify patients with vitiligo. Patient characteristics and treatments, including treatment type, episodes (treatments used without discontinuation), and sequences (treatment ep

SUBMITTER: Ringuet J 

PROVIDER: S-EPMC12171071 | biostudies-literature | 2025 May-Jun

REPOSITORIES: biostudies-literature